New England Journal of Medicine · 1974 · 33 citations · 15 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyPsychopharmacologySleep MedicineHypnotic AgentsHypnotic PharmacotherapyHypnotic TherapySedative PharmacologySedative-hypnotic PharmacologyBarbiturate TherapyHypnotic EffectsHypnotic MedicationsHypnotic PharmacologySedative-hypnotic Medications
The nonspecific depressive action of barbituric acid derivatives on the central nervous system has been used to promote sleep ever since Fischer and von Mering introduced barbital into clinical medicine in 1903. Today, barbiturates remain far and away the hypnotics used most widely by ambulatory1 and hospitalized2 patients alike. In 1973 over 20 million prescriptions for barbiturates were filled in American retail pharmacies, and about half these drugs were given specifically for hypnotic purposes. The use of barbiturate hypnotics is decreasing both here and abroad, but the rate of decline is slow.3 The therapeutic overuse of "sleeping pills" has been . . .
15
Drug Interactions with Coumarin Anticoagulants
Jan Koch‐Weser, Edward M. Sellers · New England Journal of Medicine · 1971 · 276 citations
Chronic hypnotic-drug use. Ineffectiveness, drug-withdrawal insomnia, and dependence.
Anthony Kales, Edward O. Bixler, Tjiauw Ling Tan et al. · PubMed · 1974 · 108 citations